从较早的时间到抗生素治疗败血症的好处的异质性
Rachel K Hechtman1, Patricia Kipnis2, Jennifer Cano3
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
American journal of respiratory and critical care medicine
|January 23, 2024
概括
在败血症中更快地使用抗生素显著改善了生存率,特别是在转移性癌症或休克患者中. 识别这些高益处子组可以确保及时有效的败血症治疗,改善患者的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 医疗保健服务研究 医疗服务研究
背景情况:
- 败血症的管理强调快速的抗生素的管理,以提高生存率.
- 及时服用抗生素的益处可能因不同患者子组而异.
- 识别这些子组可以优化败血症治疗方案.
研究的目的:
- 在社区发作的败血症中,从较短的抗生素时间到更短的抗生素中获得更大的生存益处的患者特征.
- 为了研究早期抗生素的治疗效果的异质性.
主要方法:
- 一项观察性队列研究,涉及173家医院的273,255名社区发作的败血症患者.
- 利用多变量波桑回归,因果森林分析和用spline建模进行后勤回归.
- 对3小时内服用抗生素的结果与3-12小时内服用抗生素的结果进行比较.
主要成果:
- 较短的抗生素治疗时间 (≤3小时) 与转移性癌症 (5.0%),休克 (7.0%) 和严重器官功能障碍 (4.8%) 的患者的绝对死亡率降低有关.
- 因果森林分析确定转移性癌症和休克是关键特征,与快速使用抗生素的最大益处有关.
- 分线分析证实了抗生素服用时间和死亡率之间的非线性关联,特别是在癌症和休克患者中.
结论:
- 在社区发病的败血症中,及时的抗生素治疗对死亡率的好处在所有患者中并不均.
- 患有转移性癌症和/或休克的患者经历了更早接受抗生素的显著更大的生存优势.
- 这些发现强调了快速服用抗生素对于患有这些特定并发症的败血症患者至关重要.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:28Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329
00:57Antibiotic Selection
53.6K
Overview
53.6K
01:20Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188